LDL receptor expression on T lymphocytes in old patients with Down syndrome
- PMID: 15705198
- PMCID: PMC549517
- DOI: 10.1186/1742-4933-2-3
LDL receptor expression on T lymphocytes in old patients with Down syndrome
Abstract
BACKGROUND: In Down syndrome patients several metabolic abnormalities have been reported, some involving the lipid metabolism. The level of LDL in plasma is the major determinant of the risk of vascular disease. There appear to be no studies on the LDL receptor in Down syndrome patients. METHODS: Flow cytometric methods for measuring the LDL receptor in peripheral blood mononuclear cells (PBMC) can identify patients with hypercholesterolemia. We applied this method in 19 old patients with Down syndrome and 23 healthy controls. RESULTS: Down syndrome patients had high levels of triglycerides and low levels of HDL, and high levels of CRP. We also found a down-regulation of LDL receptor expression. CONCLUSIONS: Down syndrome patients show no increase in the frequency of cardiovascular disease. The low incidence in cardiovascular disease despite the low level of HDL, high levels of CRP and reduction of LDL receptor expression lead to the conclusion that either these are not risk factors in these patients or that other risks factors - not yet identified - are considerably lower.
Figures
Similar articles
-
Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.Contraception. 1998 Aug;58(2):83-91. doi: 10.1016/s0010-7824(98)00074-2. Contraception. 1998. PMID: 9773262 Clinical Trial.
-
Small, dense LDL and high-sensitivity C-reactive protein (hs-CRP) in metabolic syndrome with type 2 diabetes mellitus.J Atheroscler Thromb. 2010 Apr 30;17(4):410-5. doi: 10.5551/jat.1891. Epub 2010 Mar 3. J Atheroscler Thromb. 2010. PMID: 20197633
-
Implication of cholesterol in cyclosporine pharmacodynamics in minimal change nephrotic syndrome.Clin Pharmacol Ther. 2003 Dec;74(6):581-90. doi: 10.1016/j.clpt.2003.09.001. Clin Pharmacol Ther. 2003. PMID: 14663460
-
Keep recycling going: New approaches to reduce LDL-C.Biochem Pharmacol. 2019 Jun;164:336-341. doi: 10.1016/j.bcp.2019.04.003. Epub 2019 Apr 4. Biochem Pharmacol. 2019. PMID: 30953636 Review.
-
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005. Am J Cardiovasc Drugs. 2005. PMID: 16259526 Review.
Cited by
-
Inter-Dependent Mechanisms Behind Cognitive Dysfunction, Vascular Biology and Alzheimer's Dementia in Down Syndrome: Multi-Faceted Roles of APP.Front Behav Neurosci. 2015 Dec 1;9:299. doi: 10.3389/fnbeh.2015.00299. eCollection 2015. Front Behav Neurosci. 2015. PMID: 26648852 Free PMC article.
References
-
- Pueschel SM, Craig WY, Haddow JE. Lipids and lipoproteins in persons with Down's syndrome. J Intellect Disabil Res. 1992;36:365–369. - PubMed
-
- Zamorano A, Guzman M, Aspillaga M, Avendano A, Gatica M. Concentration of serum lipids in children with Down's syndrome. Arch Biol Med Exp. 1991;24:49–55. - PubMed
-
- Eberhard Y, Eterradossi J, Foulon T, Groslambert P. Changes in plasma lipoproteins in adolescents with trisomy 21 in response to a physical endurance test. Pathol Biol. 1993;41:482–486. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous